STOCK TITAN

CVS Health Corporation (CVS) Stock News, Mar-Apr 2021

CVS NYSE

CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.

Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.

Rhea-AI Summary

CVS Health has surpassed $200 million in investments towards affordable housing in California, contributing to over 12,500 homes across 130 communities. A recent $12.1 million investment will finance LINC Housing's new development in Los Angeles County, providing 80 homes for low-income families and the homeless. In the last year, CVS invested over $43 million, leading to 850 new affordable homes across 10 cities, including provisions for seniors and veterans. The investments aim to combat housing insecurity, especially exacerbated by the COVID-19 pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
Rhea-AI Summary

CVS Health (NYSE: CVS) has launched COVID-19 antibody testing at MinuteClinic locations nationwide, following successful pilot tests at over 100 sites earlier this year. The test provides results in 15 minutes and is priced at $38. While patients can determine past infections, the test does not diagnose current COVID-19 infections. Testing is currently unavailable in Nevada but will be introduced soon. CVS has administered over 15 million diagnostic tests and continues to expand access to COVID-19 testing services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.00%
Tags
covid-19
-
Rhea-AI Summary

CVS Health has administered over 10 million COVID-19 vaccines as part of the Pharmacy Partnership for Long-Term Care and Federal Retail Pharmacy programs. Vaccines are available in nearly 2,000 locations across 44 states, Puerto Rico, and Washington D.C., with the potential to administer 25 million shots monthly. The company reports a 97% drop in COVID-19 cases and a 94% reduction in deaths in nursing homes. CVS is focused on equitable vaccine access for underserved communities, with significant efforts in outreach and community vaccination sites.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
covid-19
Rhea-AI Summary

CVS Health has unveiled its Transform Health 2030 initiative, focusing on four pillars: Healthy People, Healthy Business, Healthy Community, and Healthy Planet. The goals include facilitating 65 billion health care interactions and investing over $85 billion in inclusive wellness by 2030. Significant achievements from 2020 include administering over 15 million COVID-19 tests and expanding the HealthHUB model to 650 locations. The 2020 CSR report also addresses social inequity, with commitments to support Black and diverse communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none
-
Rhea-AI Summary

CVS Health (NYSE: CVS) announced plans to administer COVID-19 vaccines starting on March 31, 2021 at select locations in West Virginia. Appointments can be booked beginning March 30. Vaccinations will be available for individuals meeting state criteria, K-12 teachers, and childcare workers. CVS aims to enhance vaccine access, with no cost for insured patients. The initiative spans hundreds of locations nationwide, with a capacity to administer 20-25 million shots monthly as supply increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
-
Rhea-AI Summary

CVS Health announced that it will begin administering COVID-19 vaccines at two locations in Delaware starting March 31, 2021. Appointments for the vaccine will be available for booking from March 30. Eligible individuals include those meeting state criteria, K-12 teachers, and childcare workers. CVS aims to expand vaccination efforts as supply increases, ultimately being able to deliver 20-25 million shots per month across the country. Vaccination is free for insured patients and those qualifying for federal assistance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
Rhea-AI Summary

CVS Health announced plans to start administering COVID-19 vaccines at five select locations in New Mexico beginning March 31, 2021. Appointments for vaccinations will open on March 30. Eligible recipients include individuals meeting state criteria, K-12 teachers, and childcare workers. The vaccines will be provided at no cost for insured patients and through a federal program for the uninsured. CVS plans to gradually expand vaccination access across more locations in New Mexico as supply increases, aiming to administer up to 25 million shots monthly across the country.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
-
Rhea-AI Summary

CVS Health announced it will start administering COVID-19 vaccines on March 31 at select CVS Pharmacy locations in Washington. Appointments can be booked starting March 30, with vaccinations for individuals meeting state criteria, including K-12 teachers and childcare workers. The service is free for insured patients and uninsured individuals through a federal program. Initially, vaccines will be offered at select locations in Burien, Lakewood, and Seattle, with plans for expansion as vaccine supply increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
covid-19
-
Rhea-AI Summary

CVS Health has launched COVID-19 antibody testing at nearly 60 MinuteClinic locations across Massachusetts, providing results in just 15 minutes. The service is intended to assess previous exposure to the virus and costs $38. This initiative is part of CVS Health's broader commitment to accessible COVID-19 testing, with over 15 million tests administered across more than 4,800 pharmacy locations nationwide. MinuteClinic aims to meet the growing demand for affordable testing by leveraging its convenient locations and extended hours.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
covid-19
Rhea-AI Summary

CVS Health (NYSE: CVS) has announced the launch of COVID-19 antibody testing at over 100 MinuteClinic locations in Texas. This point-of-care test, which costs $38, provides results within 15 minutes, assessing prior exposure to the virus. MinuteClinic offers extended hours and may bill Medicaid for eligible patients. CVS Health has conducted more than 15 million COVID-19 tests nationwide and is exploring further service expansions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
covid-19

FAQ

What is the current stock price of CVS Health (CVS)?

CVS Health (CVS) last closed at $79.96.

What is the market cap of CVS Health (CVS)?

The market cap of CVS Health (CVS) is approximately $102.3B.